Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Gastroenterology|July 1, 2018
Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and CirrhosisRafael Esteban, Juan A Pineda, Jose Luis Calleja, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2019
Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced FibrosisJavier Ampuero, Raluca Pais, Rocío Aller, et al.Frontiers in Public Health|February 8, 2024
Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement interventionInês Vaz-Pinto, Enrique Ortega, Ivan Chivite, et al.Alimentary Pharmacology & Therapeutics|October 25, 2018
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesityJavier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 31, 2018
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohortMarc Puigvehí, Beatriz De Cuenca, Ana Viu, et al.Revista Espanola De Enfermedades Digestivas|October 29, 2019
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)Javier Crespo, Albillos Albillos, María Buti, et al.Gastroenterologia Y Hepatologia|October 10, 2019
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)Javier Crespo, Agustín Albillos, María Buti, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2025
Defining non-invasive criteria for indicating drug therapy in metabolic-associated steatotic liver disease in clinical practiceAntonio Olveira, Javier Crespo, Luis Ibañez-Samaniego, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2017
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 InfectionJavier Crespo, Jose Luis Calleja, Inmaculada Fernández, et al.Journal of Hepatology|February 13, 2017
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohortJose Luis Calleja, Javier Crespo, Diego Rincón, et al.Pageof 8